tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BMY Stock Latest News

Colgate-Palmolive names Bristol-Myers CEO Boerner to board
The FlyColgate-Palmolive names Bristol-Myers CEO Boerner to board
5h ago
CL
BMY
Curanex appoints two research experts to board of directors
PremiumThe Fly
Curanex appoints two research experts to board of directors
2d ago
BMY
CURX
Balanced Outlook on BMY: Positive Mezigdomide Phase III Data Support CELMoD Platform, but Long-Term Execution Risks Warrant Hold Rating
PremiumRatings
Balanced Outlook on BMY: Positive Mezigdomide Phase III Data Support CELMoD Platform, but Long-Term Execution Risks Warrant Hold Rating
4d ago
BMY
Bristol Myers reports ‘positive’ Phase 3 results from SUCCESSOR-2 study
PremiumThe Fly
Bristol Myers reports ‘positive’ Phase 3 results from SUCCESSOR-2 study
4d ago
BMY
Controversial Prasad leaving FDA, NYT reports
PremiumThe Fly
Controversial Prasad leaving FDA, NYT reports
4d ago
AZN
BMY
Bristol Myers announces U.S. FDA approved Sotyktu for treatment of PsA
PremiumThe FlyBristol Myers announces U.S. FDA approved Sotyktu for treatment of PsA
4d ago
BMY
Bristol-Myers Squibb Tracks Real-World Impact of KarXT in Schizophrenia
Premium
Company Announcements
Bristol-Myers Squibb Tracks Real-World Impact of KarXT in Schizophrenia
6d ago
BMY
Bristol Myers price target raised to $70 from $65 at UBS
Premium
The Fly
Bristol Myers price target raised to $70 from $65 at UBS
7d ago
BMY
Bristol Myers Squibb call volume above normal and directionally bullish
PremiumThe Fly
Bristol Myers Squibb call volume above normal and directionally bullish
9d ago
BMY
Barclays Names Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) as Top Pharma Stocks to Buy Now
PremiumMarket News
Barclays Names Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) as Top Pharma Stocks to Buy Now
12d ago
BMY
LLY
Prothena expects to end year with $255M in cash, equivalents
PremiumThe Fly
Prothena expects to end year with $255M in cash, equivalents
13d ago
BMY
NVO
Tango Therapeutics weakness an ‘over reaction,’ says Stifel
PremiumThe Fly
Tango Therapeutics weakness an ‘over reaction,’ says Stifel
14d ago
BMY
RVMD
Bristol Myers: Biokin reports ‘positive’ results from Phase 3 study of iza-bren
PremiumThe FlyBristol Myers: Biokin reports ‘positive’ results from Phase 3 study of iza-bren
15d ago
BMY
Bristol-Myers Squibb Advances Pediatric Lymphoma Combo, Signaling Quiet Upside for BMY Investors
Premium
Company Announcements
Bristol-Myers Squibb Advances Pediatric Lymphoma Combo, Signaling Quiet Upside for BMY Investors
15d ago
BMY
Bristol Myers initiated with a Sector Perform at RBC Capital
Premium
The Fly
Bristol Myers initiated with a Sector Perform at RBC Capital
16d ago
BMY
Bristol-Myers Squibb’s New Rheumatoid Arthritis Trial: What Early Pipeline Moves Mean for BMY Investors
PremiumCompany Announcements
Bristol-Myers Squibb’s New Rheumatoid Arthritis Trial: What Early Pipeline Moves Mean for BMY Investors
17d ago
BMY
Bristol Myers’ Reblozyl shows positive results in alpha-thalassemia study
PremiumThe Fly
Bristol Myers’ Reblozyl shows positive results in alpha-thalassemia study
18d ago
BMY
Bristol Myers price target raised to $75 from $66 at Piper Sandler
PremiumThe Fly
Bristol Myers price target raised to $75 from $66 at Piper Sandler
18d ago
BMY
BMY’s Mavacamten Safety Extension Wraps Up, Sharpening the Long-Term Outlook in Hypertrophic Cardiomyopathy
PremiumCompany Announcements
BMY’s Mavacamten Safety Extension Wraps Up, Sharpening the Long-Term Outlook in Hypertrophic Cardiomyopathy
20d ago
BMY
Barclays Bank (BCS) Names Four Pharma Stocks to Buy Now
PremiumMarket NewsBarclays Bank (BCS) Names Four Pharma Stocks to Buy Now
20d ago
BCS
BMY
Bristol Myers initiated with an Overweight at Barclays
Premium
The Fly
Bristol Myers initiated with an Overweight at Barclays
21d ago
BMY
FDA to begin requiring on clinical trial
Premium
The Fly
FDA to begin requiring on clinical trial
22d ago
AZN
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >